1 Study Coverage 1.1 PECAM-1 Antibody Product Introduction 1.2 Market by Type 1.2.1 Global PECAM-1 Antibody Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Mouse 1.2.3 Rabbit 1.2.4 Others 1.3 Market by Application 1.3.1 Global PECAM-1 Antibody Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Laboratory 1.3.3 Hospital 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global PECAM-1 Antibody Sales Estimates and Forecasts 2017-2028 2.2 Global PECAM-1 Antibody Revenue Estimates and Forecasts 2017-2028 2.3 Global PECAM-1 Antibody Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global PECAM-1 Antibody Sales by Region 2.4.1 Global PECAM-1 Antibody Sales by Region (2017-2022) 2.4.2 Global Sales PECAM-1 Antibody by Region (2023-2028) 2.5 Global PECAM-1 Antibody Revenue by Region 2.5.1 Global PECAM-1 Antibody Revenue by Region (2017-2022) 2.5.2 Global PECAM-1 Antibody Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global PECAM-1 Antibody Sales by Manufacturers 3.1.1 Global Top PECAM-1 Antibody Manufacturers by Sales (2017-2022) 3.1.2 Global PECAM-1 Antibody Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of PECAM-1 Antibody in 2021 3.2 Global PECAM-1 Antibody Revenue by Manufacturers 3.2.1 Global PECAM-1 Antibody Revenue by Manufacturers (2017-2022) 3.2.2 Global PECAM-1 Antibody Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by PECAM-1 Antibody Revenue in 2021 3.3 Global PECAM-1 Antibody Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global PECAM-1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global PECAM-1 Antibody Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global PECAM-1 Antibody Sales by Type 4.1.1 Global PECAM-1 Antibody Historical Sales by Type (2017-2022) 4.1.2 Global PECAM-1 Antibody Forecasted Sales by Type (2023-2028) 4.1.3 Global PECAM-1 Antibody Sales Market Share by Type (2017-2028) 4.2 Global PECAM-1 Antibody Revenue by Type 4.2.1 Global PECAM-1 Antibody Historical Revenue by Type (2017-2022) 4.2.2 Global PECAM-1 Antibody Forecasted Revenue by Type (2023-2028) 4.2.3 Global PECAM-1 Antibody Revenue Market Share by Type (2017-2028) 4.3 Global PECAM-1 Antibody Price by Type 4.3.1 Global PECAM-1 Antibody Price by Type (2017-2022) 4.3.2 Global PECAM-1 Antibody Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global PECAM-1 Antibody Sales by Application 5.1.1 Global PECAM-1 Antibody Historical Sales by Application (2017-2022) 5.1.2 Global PECAM-1 Antibody Forecasted Sales by Application (2023-2028) 5.1.3 Global PECAM-1 Antibody Sales Market Share by Application (2017-2028) 5.2 Global PECAM-1 Antibody Revenue by Application 5.2.1 Global PECAM-1 Antibody Historical Revenue by Application (2017-2022) 5.2.2 Global PECAM-1 Antibody Forecasted Revenue by Application (2023-2028) 5.2.3 Global PECAM-1 Antibody Revenue Market Share by Application (2017-2028) 5.3 Global PECAM-1 Antibody Price by Application 5.3.1 Global PECAM-1 Antibody Price by Application (2017-2022) 5.3.2 Global PECAM-1 Antibody Price Forecast by Application (2023-2028) 6 North America 6.1 North America PECAM-1 Antibody Market Size by Type 6.1.1 North America PECAM-1 Antibody Sales by Type (2017-2028) 6.1.2 North America PECAM-1 Antibody Revenue by Type (2017-2028) 6.2 North America PECAM-1 Antibody Market Size by Application 6.2.1 North America PECAM-1 Antibody Sales by Application (2017-2028) 6.2.2 North America PECAM-1 Antibody Revenue by Application (2017-2028) 6.3 North America PECAM-1 Antibody Market Size by Country 6.3.1 North America PECAM-1 Antibody Sales by Country (2017-2028) 6.3.2 North America PECAM-1 Antibody Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe PECAM-1 Antibody Market Size by Type 7.1.1 Europe PECAM-1 Antibody Sales by Type (2017-2028) 7.1.2 Europe PECAM-1 Antibody Revenue by Type (2017-2028) 7.2 Europe PECAM-1 Antibody Market Size by Application 7.2.1 Europe PECAM-1 Antibody Sales by Application (2017-2028) 7.2.2 Europe PECAM-1 Antibody Revenue by Application (2017-2028) 7.3 Europe PECAM-1 Antibody Market Size by Country 7.3.1 Europe PECAM-1 Antibody Sales by Country (2017-2028) 7.3.2 Europe PECAM-1 Antibody Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific PECAM-1 Antibody Market Size by Type 8.1.1 Asia Pacific PECAM-1 Antibody Sales by Type (2017-2028) 8.1.2 Asia Pacific PECAM-1 Antibody Revenue by Type (2017-2028) 8.2 Asia Pacific PECAM-1 Antibody Market Size by Application 8.2.1 Asia Pacific PECAM-1 Antibody Sales by Application (2017-2028) 8.2.2 Asia Pacific PECAM-1 Antibody Revenue by Application (2017-2028) 8.3 Asia Pacific PECAM-1 Antibody Market Size by Region 8.3.1 Asia Pacific PECAM-1 Antibody Sales by Region (2017-2028) 8.3.2 Asia Pacific PECAM-1 Antibody Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America PECAM-1 Antibody Market Size by Type 9.1.1 Latin America PECAM-1 Antibody Sales by Type (2017-2028) 9.1.2 Latin America PECAM-1 Antibody Revenue by Type (2017-2028) 9.2 Latin America PECAM-1 Antibody Market Size by Application 9.2.1 Latin America PECAM-1 Antibody Sales by Application (2017-2028) 9.2.2 Latin America PECAM-1 Antibody Revenue by Application (2017-2028) 9.3 Latin America PECAM-1 Antibody Market Size by Country 9.3.1 Latin America PECAM-1 Antibody Sales by Country (2017-2028) 9.3.2 Latin America PECAM-1 Antibody Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa PECAM-1 Antibody Market Size by Type 10.1.1 Middle East and Africa PECAM-1 Antibody Sales by Type (2017-2028) 10.1.2 Middle East and Africa PECAM-1 Antibody Revenue by Type (2017-2028) 10.2 Middle East and Africa PECAM-1 Antibody Market Size by Application 10.2.1 Middle East and Africa PECAM-1 Antibody Sales by Application (2017-2028) 10.2.2 Middle East and Africa PECAM-1 Antibody Revenue by Application (2017-2028) 10.3 Middle East and Africa PECAM-1 Antibody Market Size by Country 10.3.1 Middle East and Africa PECAM-1 Antibody Sales by Country (2017-2028) 10.3.2 Middle East and Africa PECAM-1 Antibody Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Thermo Fisher 11.1.1 Thermo Fisher Corporation Information 11.1.2 Thermo Fisher Overview 11.1.3 Thermo Fisher PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Thermo Fisher PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Thermo Fisher Recent Developments 11.2 MilliporeSigma 11.2.1 MilliporeSigma Corporation Information 11.2.2 MilliporeSigma Overview 11.2.3 MilliporeSigma PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 MilliporeSigma PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 MilliporeSigma Recent Developments 11.3 Abcam 11.3.1 Abcam Corporation Information 11.3.2 Abcam Overview 11.3.3 Abcam PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Abcam PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Abcam Recent Developments 11.4 BioLegend 11.4.1 BioLegend Corporation Information 11.4.2 BioLegend Overview 11.4.3 BioLegend PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 BioLegend PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 BioLegend Recent Developments 11.5 Novus Biologicals 11.5.1 Novus Biologicals Corporation Information 11.5.2 Novus Biologicals Overview 11.5.3 Novus Biologicals PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Novus Biologicals PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Novus Biologicals Recent Developments 11.6 Dianova 11.6.1 Dianova Corporation Information 11.6.2 Dianova Overview 11.6.3 Dianova PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Dianova PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Dianova Recent Developments 11.7 Santa Cruz Biotechnology 11.7.1 Santa Cruz Biotechnology Corporation Information 11.7.2 Santa Cruz Biotechnology Overview 11.7.3 Santa Cruz Biotechnology PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Santa Cruz Biotechnology PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Santa Cruz Biotechnology Recent Developments 11.8 Proteintech Group 11.8.1 Proteintech Group Corporation Information 11.8.2 Proteintech Group Overview 11.8.3 Proteintech Group PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Proteintech Group PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Proteintech Group Recent Developments 11.9 R&D Systems 11.9.1 R&D Systems Corporation Information 11.9.2 R&D Systems Overview 11.9.3 R&D Systems PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 R&D Systems PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 R&D Systems Recent Developments 11.10 Miltenyi Biotec 11.10.1 Miltenyi Biotec Corporation Information 11.10.2 Miltenyi Biotec Overview 11.10.3 Miltenyi Biotec PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Miltenyi Biotec PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Miltenyi Biotec Recent Developments 11.11 Bio-Rad 11.11.1 Bio-Rad Corporation Information 11.11.2 Bio-Rad Overview 11.11.3 Bio-Rad PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Bio-Rad PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Bio-Rad Recent Developments 11.12 LifeSpan Biosciences 11.12.1 LifeSpan Biosciences Corporation Information 11.12.2 LifeSpan Biosciences Overview 11.12.3 LifeSpan Biosciences PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 LifeSpan Biosciences PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 LifeSpan Biosciences Recent Developments 11.13 Abnova 11.13.1 Abnova Corporation Information 11.13.2 Abnova Overview 11.13.3 Abnova PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.13.4 Abnova PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 Abnova Recent Developments 11.14 OriGene 11.14.1 OriGene Corporation Information 11.14.2 OriGene Overview 11.14.3 OriGene PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.14.4 OriGene PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.14.5 OriGene Recent Developments 11.15 SICGEN 11.15.1 SICGEN Corporation Information 11.15.2 SICGEN Overview 11.15.3 SICGEN PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.15.4 SICGEN PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.15.5 SICGEN Recent Developments 11.16 YO Proteins 11.16.1 YO Proteins Corporation Information 11.16.2 YO Proteins Overview 11.16.3 YO Proteins PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.16.4 YO Proteins PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.16.5 YO Proteins Recent Developments 11.17 Enzo Life Sciences 11.17.1 Enzo Life Sciences Corporation Information 11.17.2 Enzo Life Sciences Overview 11.17.3 Enzo Life Sciences PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.17.4 Enzo Life Sciences PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.17.5 Enzo Life Sciences Recent Developments 11.18 Boster 11.18.1 Boster Corporation Information 11.18.2 Boster Overview 11.18.3 Boster PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.18.4 Boster PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.18.5 Boster Recent Developments 11.19 Abeomics 11.19.1 Abeomics Corporation Information 11.19.2 Abeomics Overview 11.19.3 Abeomics PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.19.4 Abeomics PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.19.5 Abeomics Recent Developments 11.20 Rockland Immunochemicals 11.20.1 Rockland Immunochemicals Corporation Information 11.20.2 Rockland Immunochemicals Overview 11.20.3 Rockland Immunochemicals PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.20.4 Rockland Immunochemicals PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.20.5 Rockland Immunochemicals Recent Developments 11.21 Bon Opus Biosciences 11.21.1 Bon Opus Biosciences Corporation Information 11.21.2 Bon Opus Biosciences Overview 11.21.3 Bon Opus Biosciences PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.21.4 Bon Opus Biosciences PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.21.5 Bon Opus Biosciences Recent Developments 11.22 Creative Biomart 11.22.1 Creative Biomart Corporation Information 11.22.2 Creative Biomart Overview 11.22.3 Creative Biomart PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.22.4 Creative Biomart PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.22.5 Creative Biomart Recent Developments 11.23 US Biological 11.23.1 US Biological Corporation Information 11.23.2 US Biological Overview 11.23.3 US Biological PECAM-1 Antibody Sales, Price, Revenue and Gross Margin (2017-2022) 11.23.4 US Biological PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications 11.23.5 US Biological Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 PECAM-1 Antibody Industry Chain Analysis 12.2 PECAM-1 Antibody Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 PECAM-1 Antibody Production Mode & Process 12.4 PECAM-1 Antibody Sales and Marketing 12.4.1 PECAM-1 Antibody Sales Channels 12.4.2 PECAM-1 Antibody Distributors 12.5 PECAM-1 Antibody Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 PECAM-1 Antibody Industry Trends 13.2 PECAM-1 Antibody Market Drivers 13.3 PECAM-1 Antibody Market Challenges 13.4 PECAM-1 Antibody Market Restraints 14 Key Findings in The Global PECAM-1 Antibody Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global PECAM-1 Antibody Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Mouse Table 3. Major Manufacturers of Rabbit Table 4. Major Manufacturers of Others Table 5. Global PECAM-1 Antibody Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global PECAM-1 Antibody Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 7. Global PECAM-1 Antibody Sales by Region (2017-2022) & (Kg) Table 8. Global PECAM-1 Antibody Sales Market Share by Region (2017-2022) Table 9. Global PECAM-1 Antibody Sales by Region (2023-2028) & (Kg) Table 10. Global PECAM-1 Antibody Sales Market Share by Region (2023-2028) Table 11. Global PECAM-1 Antibody Revenue by Region (2017-2022) & (US$ Million) Table 12. Global PECAM-1 Antibody Revenue Market Share by Region (2017-2022) Table 13. Global PECAM-1 Antibody Revenue by Region (2023-2028) & (US$ Million) Table 14. Global PECAM-1 Antibody Revenue Market Share by Region (2023-2028) Table 15. Global PECAM-1 Antibody Sales by Manufacturers (2017-2022) & (Kg) Table 16. Global PECAM-1 Antibody Sales Share by Manufacturers (2017-2022) Table 17. Global PECAM-1 Antibody Revenue by Manufacturers (2017-2022) & (US$ Million) Table 18. Global PECAM-1 Antibody Revenue Share by Manufacturers (2017-2022) Table 19. PECAM-1 Antibody Price by Manufacturers (2017-2022) &(USD/g) Table 20. Global PECAM-1 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global PECAM-1 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PECAM-1 Antibody as of 2021) Table 22. PECAM-1 Antibody Manufacturing Base Distribution and Headquarters Table 23. Manufacturers PECAM-1 Antibody Product Offered Table 24. Date of Manufacturers Enter into PECAM-1 Antibody Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global PECAM-1 Antibody Sales by Type (2017-2022) & (Kg) Table 27. Global PECAM-1 Antibody Sales by Type (2023-2028) & (Kg) Table 28. Global PECAM-1 Antibody Sales Share by Type (2017-2022) Table 29. Global PECAM-1 Antibody Sales Share by Type (2023-2028) Table 30. Global PECAM-1 Antibody Revenue by Type (2017-2022) & (US$ Million) Table 31. Global PECAM-1 Antibody Revenue by Type (2023-2028) & (US$ Million) Table 32. Global PECAM-1 Antibody Revenue Share by Type (2017-2022) Table 33. Global PECAM-1 Antibody Revenue Share by Type (2023-2028) Table 34. PECAM-1 Antibody Price by Type (2017-2022) & (USD/g) Table 35. Global PECAM-1 Antibody Price Forecast by Type (2023-2028) & (USD/g) Table 36. Global PECAM-1 Antibody Sales by Application (2017-2022) & (Kg) Table 37. Global PECAM-1 Antibody Sales by Application (2023-2028) & (Kg) Table 38. Global PECAM-1 Antibody Sales Share by Application (2017-2022) Table 39. Global PECAM-1 Antibody Sales Share by Application (2023-2028) Table 40. Global PECAM-1 Antibody Revenue by Application (2017-2022) & (US$ Million) Table 41. Global PECAM-1 Antibody Revenue by Application (2023-2028) & (US$ Million) Table 42. Global PECAM-1 Antibody Revenue Share by Application (2017-2022) Table 43. Global PECAM-1 Antibody Revenue Share by Application (2023-2028) Table 44. PECAM-1 Antibody Price by Application (2017-2022) & (USD/g) Table 45. Global PECAM-1 Antibody Price Forecast by Application (2023-2028) & (USD/g) Table 46. North America PECAM-1 Antibody Sales by Type (2017-2022) & (Kg) Table 47. North America PECAM-1 Antibody Sales by Type (2023-2028) & (Kg) Table 48. North America PECAM-1 Antibody Revenue by Type (2017-2022) & (US$ Million) Table 49. North America PECAM-1 Antibody Revenue by Type (2023-2028) & (US$ Million) Table 50. North America PECAM-1 Antibody Sales by Application (2017-2022) & (Kg) Table 51. North America PECAM-1 Antibody Sales by Application (2023-2028) & (Kg) Table 52. North America PECAM-1 Antibody Revenue by Application (2017-2022) & (US$ Million) Table 53. North America PECAM-1 Antibody Revenue by Application (2023-2028) & (US$ Million) Table 54. North America PECAM-1 Antibody Sales by Country (2017-2022) & (Kg) Table 55. North America PECAM-1 Antibody Sales by Country (2023-2028) & (Kg) Table 56. North America PECAM-1 Antibody Revenue by Country (2017-2022) & (US$ Million) Table 57. North America PECAM-1 Antibody Revenue by Country (2023-2028) & (US$ Million) Table 58. Europe PECAM-1 Antibody Sales by Type (2017-2022) & (Kg) Table 59. Europe PECAM-1 Antibody Sales by Type (2023-2028) & (Kg) Table 60. Europe PECAM-1 Antibody Revenue by Type (2017-2022) & (US$ Million) Table 61. Europe PECAM-1 Antibody Revenue by Type (2023-2028) & (US$ Million) Table 62. Europe PECAM-1 Antibody Sales by Application (2017-2022) & (Kg) Table 63. Europe PECAM-1 Antibody Sales by Application (2023-2028) & (Kg) Table 64. Europe PECAM-1 Antibody Revenue by Application (2017-2022) & (US$ Million) Table 65. Europe PECAM-1 Antibody Revenue by Application (2023-2028) & (US$ Million) Table 66. Europe PECAM-1 Antibody Sales by Country (2017-2022) & (Kg) Table 67. Europe PECAM-1 Antibody Sales by Country (2023-2028) & (Kg) Table 68. Europe PECAM-1 Antibody Revenue by Country (2017-2022) & (US$ Million) Table 69. Europe PECAM-1 Antibody Revenue by Country (2023-2028) & (US$ Million) Table 70. Asia Pacific PECAM-1 Antibody Sales by Type (2017-2022) & (Kg) Table 71. Asia Pacific PECAM-1 Antibody Sales by Type (2023-2028) & (Kg) Table 72. Asia Pacific PECAM-1 Antibody Revenue by Type (2017-2022) & (US$ Million) Table 73. Asia Pacific PECAM-1 Antibody Revenue by Type (2023-2028) & (US$ Million) Table 74. Asia Pacific PECAM-1 Antibody Sales by Application (2017-2022) & (Kg) Table 75. Asia Pacific PECAM-1 Antibody Sales by Application (2023-2028) & (Kg) Table 76. Asia Pacific PECAM-1 Antibody Revenue by Application (2017-2022) & (US$ Million) Table 77. Asia Pacific PECAM-1 Antibody Revenue by Application (2023-2028) & (US$ Million) Table 78. Asia Pacific PECAM-1 Antibody Sales by Region (2017-2022) & (Kg) Table 79. Asia Pacific PECAM-1 Antibody Sales by Region (2023-2028) & (Kg) Table 80. Asia Pacific PECAM-1 Antibody Revenue by Region (2017-2022) & (US$ Million) Table 81. Asia Pacific PECAM-1 Antibody Revenue by Region (2023-2028) & (US$ Million) Table 82. Latin America PECAM-1 Antibody Sales by Type (2017-2022) & (Kg) Table 83. Latin America PECAM-1 Antibody Sales by Type (2023-2028) & (Kg) Table 84. Latin America PECAM-1 Antibody Revenue by Type (2017-2022) & (US$ Million) Table 85. Latin America PECAM-1 Antibody Revenue by Type (2023-2028) & (US$ Million) Table 86. Latin America PECAM-1 Antibody Sales by Application (2017-2022) & (Kg) Table 87. Latin America PECAM-1 Antibody Sales by Application (2023-2028) & (Kg) Table 88. Latin America PECAM-1 Antibody Revenue by Application (2017-2022) & (US$ Million) Table 89. Latin America PECAM-1 Antibody Revenue by Application (2023-2028) & (US$ Million) Table 90. Latin America PECAM-1 Antibody Sales by Country (2017-2022) & (Kg) Table 91. Latin America PECAM-1 Antibody Sales by Country (2023-2028) & (Kg) Table 92. Latin America PECAM-1 Antibody Revenue by Country (2017-2022) & (US$ Million) Table 93. Latin America PECAM-1 Antibody Revenue by Country (2023-2028) & (US$ Million) Table 94. Middle East and Africa PECAM-1 Antibody Sales by Type (2017-2022) & (Kg) Table 95. Middle East and Africa PECAM-1 Antibody Sales by Type (2023-2028) & (Kg) Table 96. Middle East and Africa PECAM-1 Antibody Revenue by Type (2017-2022) & (US$ Million) Table 97. Middle East and Africa PECAM-1 Antibody Revenue by Type (2023-2028) & (US$ Million) Table 98. Middle East and Africa PECAM-1 Antibody Sales by Application (2017-2022) & (Kg) Table 99. Middle East and Africa PECAM-1 Antibody Sales by Application (2023-2028) & (Kg) Table 100. Middle East and Africa PECAM-1 Antibody Revenue by Application (2017-2022) & (US$ Million) Table 101. Middle East and Africa PECAM-1 Antibody Revenue by Application (2023-2028) & (US$ Million) Table 102. Middle East and Africa PECAM-1 Antibody Sales by Country (2017-2022) & (Kg) Table 103. Middle East and Africa PECAM-1 Antibody Sales by Country (2023-2028) & (Kg) Table 104. Middle East and Africa PECAM-1 Antibody Revenue by Country (2017-2022) & (US$ Million) Table 105. Middle East and Africa PECAM-1 Antibody Revenue by Country (2023-2028) & (US$ Million) Table 106. Thermo Fisher Corporation Information Table 107. Thermo Fisher Description and Major Businesses Table 108. Thermo Fisher PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 109. Thermo Fisher PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 110. Thermo Fisher Recent Developments Table 111. MilliporeSigma Corporation Information Table 112. MilliporeSigma Description and Major Businesses Table 113. MilliporeSigma PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 114. MilliporeSigma PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 115. MilliporeSigma Recent Developments Table 116. Abcam Corporation Information Table 117. Abcam Description and Major Businesses Table 118. Abcam PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 119. Abcam PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 120. Abcam Recent Developments Table 121. BioLegend Corporation Information Table 122. BioLegend Description and Major Businesses Table 123. BioLegend PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 124. BioLegend PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 125. BioLegend Recent Developments Table 126. Novus Biologicals Corporation Information Table 127. Novus Biologicals Description and Major Businesses Table 128. Novus Biologicals PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 129. Novus Biologicals PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 130. Novus Biologicals Recent Developments Table 131. Dianova Corporation Information Table 132. Dianova Description and Major Businesses Table 133. Dianova PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 134. Dianova PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 135. Dianova Recent Developments Table 136. Santa Cruz Biotechnology Corporation Information Table 137. Santa Cruz Biotechnology Description and Major Businesses Table 138. Santa Cruz Biotechnology PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 139. Santa Cruz Biotechnology PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 140. Santa Cruz Biotechnology Recent Developments Table 141. Proteintech Group Corporation Information Table 142. Proteintech Group Description and Major Businesses Table 143. Proteintech Group PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 144. Proteintech Group PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 145. Proteintech Group Recent Developments Table 146. R&D Systems Corporation Information Table 147. R&D Systems Description and Major Businesses Table 148. R&D Systems PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 149. R&D Systems PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 150. R&D Systems Recent Developments Table 151. Miltenyi Biotec Corporation Information Table 152. Miltenyi Biotec Description and Major Businesses Table 153. Miltenyi Biotec PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 154. Miltenyi Biotec PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 155. Miltenyi Biotec Recent Developments Table 156. Bio-Rad Corporation Information Table 157. Bio-Rad Description and Major Businesses Table 158. Bio-Rad PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 159. Bio-Rad PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 160. Bio-Rad Recent Developments Table 161. LifeSpan Biosciences Corporation Information Table 162. LifeSpan Biosciences Description and Major Businesses Table 163. LifeSpan Biosciences PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 164. LifeSpan Biosciences PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 165. LifeSpan Biosciences Recent Developments Table 166. Abnova Corporation Information Table 167. Abnova Description and Major Businesses Table 168. Abnova PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 169. Abnova PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 170. Abnova Recent Developments Table 171. OriGene Corporation Information Table 172. OriGene Description and Major Businesses Table 173. OriGene PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 174. OriGene PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 175. OriGene Recent Developments Table 176. SICGEN Corporation Information Table 177. SICGEN Description and Major Businesses Table 178. SICGEN PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 179. SICGEN PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 180. SICGEN Recent Developments Table 181. YO Proteins Corporation Information Table 182. YO Proteins Description and Major Businesses Table 183. YO Proteins PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 184. YO Proteins PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 185. YO Proteins Recent Developments Table 186. Enzo Life Sciences Corporation Information Table 187. Enzo Life Sciences Description and Major Businesses Table 188. Enzo Life Sciences PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 189. Enzo Life Sciences PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 190. Enzo Life Sciences Recent Developments Table 191. Boster Corporation Information Table 192. Boster Description and Major Businesses Table 193. Boster PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 194. Boster PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 195. Boster Recent Developments Table 196. Abeomics Corporation Information Table 197. Abeomics Description and Major Businesses Table 198. Abeomics PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 199. Abeomics PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 200. Abeomics Recent Developments Table 201. Rockland Immunochemicals Corporation Information Table 202. Rockland Immunochemicals Description and Major Businesses Table 203. Rockland Immunochemicals PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 204. Rockland Immunochemicals PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 205. Rockland Immunochemicals Recent Developments Table 206. Bon Opus Biosciences Corporation Information Table 207. Bon Opus Biosciences Description and Major Businesses Table 208. Bon Opus Biosciences PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 209. Bon Opus Biosciences PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 210. Bon Opus Biosciences Recent Developments Table 211. Creative Biomart Corporation Information Table 212. Creative Biomart Description and Major Businesses Table 213. Creative Biomart PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 214. Creative Biomart PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 215. Creative Biomart Recent Developments Table 216. US Biological Corporation Information Table 217. US Biological Description and Major Businesses Table 218. US Biological PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 219. US Biological PECAM-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications Table 220. US Biological Recent Developments Table 221. Key Raw Materials Lists Table 222. Raw Materials Key Suppliers Lists Table 223. PECAM-1 Antibody Distributors List Table 224. PECAM-1 Antibody Customers List Table 225. PECAM-1 Antibody Market Trends Table 226. PECAM-1 Antibody Market Drivers Table 227. PECAM-1 Antibody Market Challenges Table 228. PECAM-1 Antibody Market Restraints Table 229. Research Programs/Design for This Report Table 230. Key Data Information from Secondary Sources Table 231. Key Data Information from Primary Sources List of Figures Figure 1. PECAM-1 Antibody Product Picture Figure 3. Global PECAM-1 Antibody Market Share by Type in 2021 & 2028 Figure 3. Mouse Product Picture Figure 4. Rabbit Product Picture Figure 5. Others Product Picture Figure 6. Global PECAM-1 Antibody Market Share by Application in 2021 & 2028 Figure 7. Laboratory Figure 8. Hospital Figure 9. Others Figure 10. PECAM-1 Antibody Report Years Considered Figure 11. Global PECAM-1 Antibody Sales 2017-2028 (Kg) Figure 12. Global PECAM-1 Antibody Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global PECAM-1 Antibody Revenue 2017-2028 (US$ Million) Figure 14. Global PECAM-1 Antibody Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 15. Global PECAM-1 Antibody Sales Market Share by Region (2017-2022) Figure 16. Global PECAM-1 Antibody Sales Market Share by Region (2023-2028) Figure 17. North America PECAM-1 Antibody Sales YoY (2017-2028) & (Kg) Figure 18. North America PECAM-1 Antibody Revenue YoY (2017-2028) & (US$ Million) Figure 19. Europe PECAM-1 Antibody Sales YoY (2017-2028) & (Kg) Figure 20. Europe PECAM-1 Antibody Revenue YoY (2017-2028) & (US$ Million) Figure 21. Asia-Pacific PECAM-1 Antibody Sales YoY (2017-2028) & (Kg) Figure 22. Asia-Pacific PECAM-1 Antibody Revenue YoY (2017-2028) & (US$ Million) Figure 23. Latin America PECAM-1 Antibody Sales YoY (2017-2028) & (Kg) Figure 24. Latin America PECAM-1 Antibody Revenue YoY (2017-2028) & (US$ Million) Figure 25. Middle East & Africa PECAM-1 Antibody Sales YoY (2017-2028) & (Kg) Figure 26. Middle East & Africa PECAM-1 Antibody Revenue YoY (2017-2028) & (US$ Million) Figure 27. The PECAM-1 Antibody Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 28. The Top 5 and 10 Largest Manufacturers of PECAM-1 Antibody in the World: Market Share by PECAM-1 Antibody Revenue in 2021 Figure 29. Global PECAM-1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 30. Global PECAM-1 Antibody Sales Market Share by Type (2017-2028) Figure 31. Global PECAM-1 Antibody Revenue Market Share by Type (2017-2028) Figure 32. Global PECAM-1 Antibody Sales Market Share by Application (2017-2028) Figure 33. Global PECAM-1 Antibody Revenue Market Share by Application (2017-2028) Figure 34. North America PECAM-1 Antibody Sales Market Share by Type (2017-2028) Figure 35. North America PECAM-1 Antibody Revenue Market Share by Type (2017-2028) Figure 36. North America PECAM-1 Antibody Sales Market Share by Application (2017-2028) Figure 37. North America PECAM-1 Antibody Revenue Market Share by Application (2017-2028) Figure 38. North America PECAM-1 Antibody Sales Share by Country (2017-2028) Figure 39. North America PECAM-1 Antibody Revenue Share by Country (2017-2028) Figure 40. U.S. PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 41. Canada PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 42. Europe PECAM-1 Antibody Sales Market Share by Type (2017-2028) Figure 43. Europe PECAM-1 Antibody Revenue Market Share by Type (2017-2028) Figure 44. Europe PECAM-1 Antibody Sales Market Share by Application (2017-2028) Figure 45. Europe PECAM-1 Antibody Revenue Market Share by Application (2017-2028) Figure 46. Europe PECAM-1 Antibody Sales Share by Country (2017-2028) Figure 47. Europe PECAM-1 Antibody Revenue Share by Country (2017-2028) Figure 48. Germany PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 49. France PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 50. U.K. PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 51. Italy PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 52. Russia PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 53. Asia Pacific PECAM-1 Antibody Sales Market Share by Type (2017-2028) Figure 54. Asia Pacific PECAM-1 Antibody Revenue Market Share by Type (2017-2028) Figure 55. Asia Pacific PECAM-1 Antibody Sales Market Share by Application (2017-2028) Figure 56. Asia Pacific PECAM-1 Antibody Revenue Market Share by Application (2017-2028) Figure 57. Asia Pacific PECAM-1 Antibody Sales Share by Region (2017-2028) Figure 58. Asia Pacific PECAM-1 Antibody Revenue Share by Region (2017-2028) Figure 59. China PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 60. Japan PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 61. South Korea PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 62. India PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 63. Australia PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 64. Taiwan PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 65. Indonesia PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 66. Thailand PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 67. Malaysia PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 68. Philippines PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 69. Latin America PECAM-1 Antibody Sales Market Share by Type (2017-2028) Figure 70. Latin America PECAM-1 Antibody Revenue Market Share by Type (2017-2028) Figure 71. Latin America PECAM-1 Antibody Sales Market Share by Application (2017-2028) Figure 72. Latin America PECAM-1 Antibody Revenue Market Share by Application (2017-2028) Figure 73. Latin America PECAM-1 Antibody Sales Share by Country (2017-2028) Figure 74. Latin America PECAM-1 Antibody Revenue Share by Country (2017-2028) Figure 75. Mexico PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 76. Brazil PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 77. Argentina PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 78. Middle East and Africa PECAM-1 Antibody Sales Market Share by Type (2017-2028) Figure 79. Middle East and Africa PECAM-1 Antibody Revenue Market Share by Type (2017-2028) Figure 80. Middle East and Africa PECAM-1 Antibody Sales Market Share by Application (2017-2028) Figure 81. Middle East and Africa PECAM-1 Antibody Revenue Market Share by Application (2017-2028) Figure 82. Middle East and Africa PECAM-1 Antibody Sales Share by Country (2017-2028) Figure 83. Middle East and Africa PECAM-1 Antibody Revenue Share by Country (2017-2028) Figure 84. Turkey PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 85. Saudi Arabia PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 86. UAE PECAM-1 Antibody Revenue (2017-2028) & (US$ Million) Figure 87. PECAM-1 Antibody Value Chain Figure 88. PECAM-1 Antibody Production Process Figure 89. Channels of Distribution Figure 90. Distributors Profiles Figure 91. Bottom-up and Top-down Approaches for This Report Figure 92. Data Triangulation Figure 93. Key Executives Interviewed

Thermo Fisher MilliporeSigma Abcam BioLegend Novus Biologicals Dianova Santa Cruz Biotechnology Proteintech Group R&D Systems Miltenyi Biotec Bio-Rad LifeSpan Biosciences Abnova OriGene SICGEN YO Proteins Enzo Life Sciences Boster Abeomics Rockland Immunochemicals Bon Opus Biosciences Creative Biomart US Biological